Toldo, Stefano
Bussani, Rossana
Nuzzi, Vincenzo
Bonaventura, Aldo
Mauro, Adolfo G.
Cannatà , Antonio
Pillappa, Raghavendra
Sinagra, Gianfranco
Nana-Sinkam, Patrick
Sime, Patricia
Abbate, Antonio http://orcid.org/0000-0002-1930-785X
Funding for this research was provided by:
United States of America National Institute of Health NHLBI (R01HL150115)
Article History
Received: 13 August 2020
Revised: 1 October 2020
Accepted: 12 October 2020
First Online: 20 October 2020
Compliance with ethical standards
:
: Dr. Toldo reports grants from Olatec, grants from Kiniksa during the conduct of the study. Dr. Bonaventura reports a travel award grant from Kiniksa, outside the submitted work. Dr. Abbate reports grants and personal fees from Olatec, grants from Novartis, grants and personal fees from Kiniksa, grants from Regeneron, during the conduct of the study. In addition, Dr. Abbate has a patent on a Cryopyrin inhibitor issued. All other authors report no conflicts relevant to this work.
: The research was conducted on de-identified post-mortem samples; this research did not involve any human living subjects.
Free to read: This content has been made available to all.